A Data Science and Healthcare Analytics Company
Our commitment to helping healthcare organizations use data and
analytics to provide personalized care earned a high score in the
KLAS Value-Based Care Managed Services segment.
Analytics and Insights for Population Health
Clients use our cloud-based technology, identification and stratification methodology and insights derived from our AI-driven data models to identify and engage the right patients with the right care at the right time, leading to improved cost, quality and health outcomes.
Learn more
Data Science for Healthcare's Intractable Problems
PhD-level data scientists in the Geneia Data Intelligence Lab develop and deliver innovative AI-driven models that fuel our product insights. Our novel predictive and prescriptive models help identify patients at risk for poor health outcomes, complications from chronic conditions, high cost procedures, opioid addiction, and more.
Learn moreEnhanced ID and Stratification for Greatest Impact
Our enhanced identification and stratification process, which uses retrospective claims data and our in-house data models, allows healthcare organizations to accurately identify and prioritize patients by clinical markers, risk, cost, utilization or a combination.
Learn more
Actionable Insights
and Workflow for Engagement
Our technology was built to support population health management at scale, driving proactive, sustained and prioritized engagement. Insights and information at the population and individual patient levels allow healthcare organizations to take actions and inform clinical and operational decisions.
Learn moreClients & Partners:
How Plans are Supporting Provider Partners to Achieve Value-Based Care Goals
Presented in collaboration with World Congress
GDI Lab model to predict specialty drug use
Predicting the use of Humira and TNF inhibitors in RA patients
Geneia Data Intelligence Lab: Your Questions Answered
A conversation with Heather Lavoie, Fred Rahmanian and Barry Chaiken, MD
Hypertension: Putting analytics into action
Meet Jackie. She’s stage 2, medium risk for a hypertensive complication.
HIMSS21: Resources for Hospitals and Health Systems
A new case study about improving revenue and quality performance.
GDI Lab
Hypertension: Who is most at risk?
Check your risk for hypertension complications & get a sneak peek into our patent-pending Hypertension Complications Model.